Dermatological adverse events with taxane chemotherapy

Taxanes (docetaxel and paclitaxel) are among the most commonly prescribed anticancer drugs approved for the treatment of metastatic or locally advanced breast, non-small cell lung, prostate, gastric, head and neck, and ovarian cancers, as well as in the adjuvant setting for operable node-positive br...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Eur J Dermatol
Auteurs principaux: Sibaud, Vincent, Lebœuf, Nicole R., Roche, Henri, Belum, Viswanath R., Gladieff, Laurence, Deslandres, Marion, Montastruc, Marion, Eche, Audrey, Vigarios, Emmanuelle, Dalenc, Florence, Lacouture, Mario E.
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5526115/
https://ncbi.nlm.nih.gov/pubmed/27550571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1684/ejd.2016.2833
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires